Did you know?
ChinaBio® LLC is a consulting and advisory firm that helps Western companies come to China. We assist our clients with China strategy development, market research and analysis, partner/technology searches, competitive surveys, and market entry planning.

>> Learn more…
Site Search

>> Advanced Search

  Quick Search:

Free Newsletter

  Email address:

Accord Pharma to Buy the Rest of Shenzhen Sinopharm TCM

publication date: Aug 18, 2010
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.

Shenzhen Accord Pharmaceutical will gain full control of Shenzhen Sinopharm Traditional Chinese Medicine by buying the 52.6% stake it doesn’t already own. At 27 million RMB ($4 million), the acquisition is a relatively small one. Accord is buying the stake from industry giant Sinopharm. More details....

Stock Symbols: (SHEX: 000028) (SHEX: 01099)

Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...



Partner Events

China Medical Affairs Summit
June 12-13, 2014
Shanghai, China

>>More events...
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Partners